Arkolith/Insider Trading/INO/Form 4

Sumner Michael John

Chief Medical OfficerINOVIO PHARMACEUTICALS, INC. (INO) · full profile →Form 4 · filed Feb 27, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 26, 2026Tax withholding(F)4K$1.79$7K31K
Feb 26, 2026Option exercise(M)12K——34K
Feb 26, 2026Option exercise(M)5K——23K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 26, 2026Option exercise(M)5K—$05K
Feb 26, 2026Option exercise(M)12K—$023K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001936799-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML